Award notice
🇪🇺 TED
304490-2026
Ustekinumab Biosimilar via SC
🌍 ES
Contenu du marché
Extrait automatiquementDescription
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg para los Centros dependientes del Servicio Murciano de Salud
Valeur estimée
2 227 500,00 EUR
Type de procédure
Open
Région
Murcia (ES620)
Critères d'attribution
Criterion: Type: Price Description: PRECIO. Category of award weight criterion: Weight (points, exact) Award criterion number: 100
Secteur
Immunosuppressive agents
Marchés similaires
Prior notice
08/05/2026
Managed Service for Endoscopy, Radiology, Cath Labs & CTC, and Theatres – Preliminary Market Engagement (Market Engagement Event)
GB
Prior notice
08/05/2026
Procurement of 1 No Navigational Robot-assisted Bronchoscopy platform
GB
J-145
Prior notice
08/05/2026
Supply of Independent Living Equipment
GB
Prior notice
08/05/2026
NHS National Framework for Tafamidis
GB